Implications of Selection Bias Due to Delayed Study Entry in Clinical Genomic StudiesSamantha Brown, Priyanka Shivdasani, Nikolaus Schultz et al.|JAMA Oncology|2021Cited by 52
Correlation Between Surrogate End Points and Overall Survival in a Multi-institutional Clinicogenomic Cohort of Patients With Non–Small Cell Lung or Colorectal CancerKenneth L. Kehl, Pasi A. Jänne, Gregory J. Riely et al.|JAMA Network Open|2021Cited by 40
Genomic analysis of early-stage lung cancer reveals a role for TP53 mutations in distant metastasisDebra Van Egeren, Kevin M. Haigis, Khushi Kohli et al.|Scientific Reports|2022Cited by 21
Collaborating across sectors in service of open science, precision oncology, and patients: an overview of the AACR Project GENIE (Genomics Evidence Neoplasia Information Exchange) Biopharma Collaborative (BPC)Alyssa Acebedo, Celeste Yu, Philippe L. Bédard et al.|ESMO Real World Data and Digital Oncology|2025Cited by 4
PROTEASOME REGULATION OF CASPASE-8: SIGNIFICANCE IN CANCERMichael V. Fiandalo|UKnowledge (University of Kentucky)|2012Cited by 0